Median CD73 expression in glioblastoma was similar to that of non-small-cell lung cancer (NSCLC), pancreatic ductal carcinoma, and colorectal carcinoma, tumor types in which anti-CD73 antibody therapy has shown promise in early-stage clinical trials54,55. This evidence concerns the gene NT5E and colorectal carcinoma.